The non-hospital environment particularly poultry farms and abattoirs are fast becoming reservoir channels for the transmission of antibiotic resistant bacteria including those that produce metallo beta-lactamases (MBLs). Foodproducing animal's habouring multidrug resistant bacteria including those that produce metallo-beta-lactamases (MBLs) poses health risks to the human population. This study investigated the prevalence of bla IMP-1 and bla VIM-1 MBL genes in Pseudomonas aeruginosa isolates from food-producing animals by multiplex PCR technique. Anal swab samples (n=120) were bacteriologically analyzed on cetrimide selective agar for the selective isolation of P. aeruginosa isolates. Antibiogram was carried out as per the Clinical and Laboratory Standard Institute (CLSI) criteria. The production of MBLs was detected phenotypically and genotypically using the modified Hodges test method and multiplex PCR technique respectively. DNA products were run on 1.5 % agarose gel, and visualized using a UV transilluminator at 260 nm. Data was analyzed statistically using SPSS version 23.0. Out of the 120 anal swab samples, a total of 43 (35.8 %) isolates of P. aeruginosa was bacteriologically recovered. The P. aeruginosa isolates were found to be resistant to ampicillin (88.4 %), cefotaxime (81.4 %), gentamicin (79.1 %), sulphamethoxazole-trimethoprim (72.1 %), oxacillin (76.7 %), nitrofurantoin (76.7 %), meropenem (62.8 %), ofloxacin (67.4 %), imipenem (65.1 %) and cloxacillin (69.8 %). MBL was phenotypically detected in 15 (34.9 %) isolates of P. aeruginosa. However, the multiplex PCR technique significantly confirmed MBL production in only 12 (27.9) isolates of P. aeruginosa (p<0.001) that harboured the bla IMP-1 MBL genes. The bla VIM-1 MBL genes were not detected in the MBL positive P. aeruginosa phenotypes. The P. aeruginosa isolates that harboured the bla IMP-1 MBL genes were found to be multiply resistant. This study reported for the first time the prevalence of bla IMP-1 MBL genes from P. aeruginosa isolates from anal swab samples of food-producing animals in Abakaliki, Nigeria. The long-term exposure of food-producing animals to antibiotics could cause accumulation of antibiotic resistance determinants in the gut microbiota of these animals.
Background: Bacteria produce antibiotic-degrading enzymes such as carbapenemases. Carbapenemases are a consortium of carbapenem-hydrolyzing enzymes such as metallo-β-lactamase (MBL) that gives Gram-negative bacteria the exceptional ability to degrade and render the carbapenems inefficacious.Aim: This study evaluated the antibiogram, multiple antibiotic resistance and occurrence of MBL-producing E. coli from cloacal swabs of poultry birds in a local poultry farm in Abakaliki, Nigeria. Materials and methods:A total of 40 cloacal swab samples from the cloacal region of poultry birds were bacteriologically analyzed for the isolation of E. coli. E. coli isolates were identified using standard microbiology techniques and the antibiogram of the isolates was determined using the disk diffusion technique. The multidrug resistance nature of the E. coli isolates was determined using multiple antibiotics resistance index (MARI) protocol while MBL production was phenotypically confirmed using the inhibition based assay.Results: A total of 29 (72.5%) E. coli isolates was recovered from the 40 cloacal swab samples. The E. coli isolates were highly resistant to imipenem (31%), meropenem (58.6%), ertapenem (75.9%), cefotaxime (55.2%), ciprofloxacin (89.7%), cefoxitin (93.1%). and ceftazidime (69.0%). MBL production was phenotypically detected in 3 (10.3%) E. coli isolates out of the 29 isolates of E. coli recovered in this study. The resistant E. coli isolates were multiply resistant to antibiotics in the class of fluoroquinolones, cephalosporins, aminoglycosides and carbapenems; and they had a multiple antibiotic resistance of 0.4 on average. Conclusion:This presumptive study has shown that E. coli isolates of poultry origin produce MBL. The emergence and spread of drug resistant bacteria in the community can be contained if we use antibiotics rationally and find alternative measures for promoting animal growth without the use of antimicrobial agents. as metallo-β-lactamase (MBL)-producing bacteria has not yet been institutionalized in our healthcare system. And this could contribute to poor prognosis of the patient as well as lead to inappropriate use or application of antimicrobial therapy. The emergence of new beta-lactamases such as metallo-β-lactamases (MBLs), extended spectrum β-lactamases (ESBLs) and AmpC
Antimicrobial resistance (AMR) occurs when microorganisms fail to respond to the therapeutic onslaught of antibiotics. Extended-spectrum beta-lactamase (ESBL) and AmpC enzymes are important AMR mechanisms that erode the efficacy of important antibiotics. Here, we report on the detection and susceptibility of ESBL-and AmpC-producing bacteria from livestock and poultry environments. Bacteriological and molecular biology tools were used for the isolation and characterization of bacteria. Combined disk diffusion methods and PCR were used to screen and confirm ESBL and AmpC production. ESBL was phenotypically detected in E. coli, Klebsiella species, and P. aeruginosa for samples from poultry at the rate of 4%, 1%, 2% while samples from livestock milieus had ESBL-positive bacteria at the rate of 5%, 2%, 4% for E. coli, Klebsiella species and P. aeruginosa respectively. AmpC was phenotypically detected in E. coli (3%), Klebsiella species (2%), and P. aeruginosa isolates (1%) for samples from poultry milieus. For samples from livestock milieus, AmpC was phenotypically detected in E. coli (7%), Klebsiella species (3%), and P. aeruginosa (6%). The ESBL-and AmpC-positive bacteria showed significant levels of reduced susceptibility to the carbapenems and cephalosporins. PCR detected CTX-M-15 genes (20%) and FOX-1 genes (25%) which mediated ESBL and AmpC resistance in bacteria. These findings have led to the identification of key functional genes that cause bacterial resistance in southeast Nigeria, and focus attention on the importance of surveillance and monitoring to mitigate the transmission of AMR in the environment, as antibiotic therapy could be affected.
Antimicrobial resistance (AMR) occurs when microorganisms fail to respond to the therapeutic onslaught of antibiotics. Extended-spectrum beta-lactamase (ESBL) and AmpC enzymes are important AMR mechanisms that erode the efficacy of important antibiotics. Here, we report on the detection and susceptibility of ESBL-and AmpC-producing bacteria from livestock and poultry environments. Bacteriological and molecular biology tools were used for the isolation and characterization of bacteria. Combined disk diffusion methods and PCR were used to screen and confirm ESBL and AmpC production. ESBL was phenotypically detected in E. coli, Klebsiella species, and P. aeruginosa for samples from poultry at the rate of 4%, 1%, and 2% while samples from livestock milieus had ESBL-positive bacteria at the rate of 5%, 2%, 4% for E. coli, Klebsiella species and P. aeruginosa respectively. AmpC was phenotypically detected in E. coli (3%), Klebsiella species (2%), and P. aeruginosa isolates (1%) for samples from poultry milieus. For samples from livestock milieus, AmpC was phenotypically detected in E. coli (7%), Klebsiella species (3%), and P. aeruginosa (6%). The ESBL-and AmpC-positive bacteria showed significant levels of reduced susceptibility to the carbapenems and cephalosporins. PCR detected CTX-M-15 genes (20%) and FOX-1 genes (25%) which mediated ESBL and AmpC resistance in bacteria. These findings have led to the identification of key functional genes that cause bacterial resistance in southeast Nigeria, and focus attention on the importance of surveillance and monitoring to mitigate the transmission of AMR in the environment, as antibiotic therapy could be affected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.